Human disease
prostate cancer
Mondo defines it as: “A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas.”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 2335 | Prostate cancer | The group's name | 1 | Human disease |
31.5
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
Open Targets links none of these groups' human genes to this disease.
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Abarelix | None of these genes | Approved |
| Abiraterone | None of these genes | Approved |
| Abiraterone Acetate | None of these genes | Approved |
| Apalutamide | None of these genes | Approved |
| Atrasentan | None of these genes | Approved |
| Bicalutamide | None of these genes | Approved |
| Cabazitaxel | None of these genes | Approved |
| Capromab | None of these genes | Approved |
| Choline | None of these genes | Approved |
| Cyproterone | None of these genes | Approved |
| Darolutamide | None of these genes | Approved |
| Degarelix | None of these genes | Approved |
| Enzalutamide | None of these genes | Approved |
| Estramustine | None of these genes | Approved |
| Fluciclovine | None of these genes | Approved |
| Flutamide | None of these genes | Approved |
| Histrelin | None of these genes | Approved |
| Hydroxyflutamide | None of these genes | Approved |
| Leuprolide | None of these genes | Approved |
| Masoprocol | None of these genes | Approved |
| Mitoxantrone | None of these genes | Approved |
| Nilutamide | None of these genes | Approved |
| Polyestradiol Phosphate | None of these genes | Approved |
| Prednisone | None of these genes | Approved |
| Radium Ra 223 Dichloride | None of these genes | Approved |
| Relugolix | None of these genes | Approved |
| Sipuleucel-T | None of these genes | Approved |
| Talazoparib | None of these genes | Approved |
| Vipivotide Tetraxetan Lutetium | None of these genes | Approved |
| Zoledronic Acid Anhydrous | None of these genes | Approved |
| Abemaciclib | None of these genes | Phase 3 |
| Acetaminophen | None of these genes | Phase 3 |
| Aflibercept | None of these genes | Phase 3 |
| Aglatimagene Besadenovec | None of these genes | Phase 3 |
| Amonafide | None of these genes | Phase 3 |
| Aspirin | None of these genes | Phase 3 |
| Atezolizumab | None of these genes | Phase 3 |
| Atorvastatin | None of these genes | Phase 3 |
| Bevacizumab | None of these genes | Phase 3 |
| Bupivacaine | None of these genes | Phase 3 |
| Buserelin | None of these genes | Phase 3 |
| Cabozantinib | None of these genes | Phase 3 |
| Calcitriol | None of these genes | Phase 3 |
| Capivasertib | None of these genes | Phase 3 |
| Carboplatin | None of these genes | Phase 3 |
| Cholecalciferol | None of these genes | Phase 3 |
| Clodronic Acid | None of these genes | Phase 3 |
| Custirsen | None of these genes | Phase 3 |
| Cyproterone Acetate | None of these genes | Phase 3 |
| Dalteparin Sodium | None of these genes | Phase 3 |
| Dasatinib Anhydrous | None of these genes | Phase 3 |
| Denosumab | None of these genes | Phase 3 |
| Dexamethasone | None of these genes | Phase 3 |
| Diethylstilbestrol | None of these genes | Phase 3 |
| Docetaxel Anhydrous | None of these genes | Phase 3 |
| Doxorubicin | None of these genes | Phase 3 |
| Dutasteride | None of these genes | Phase 3 |
| Epoetin Alfa | None of these genes | Phase 3 |
| Epoetin Beta | None of these genes | Phase 3 |
| Ergocalciferol | None of these genes | Phase 3 |
| Estradiol | None of these genes | Phase 3 |
| Estramustine Phosphate | None of these genes | Phase 3 |
| Etoposide | None of these genes | Phase 3 |
| Everolimus | None of these genes | Phase 3 |
| Fentanyl | None of these genes | Phase 3 |
| Fluzoparib | None of these genes | Phase 3 |
| Galeterone | None of these genes | Phase 3 |
| Galgenprostucel-L | None of these genes | Phase 3 |
| Gonadorelin | None of these genes | Phase 3 |
| Goserelin | None of these genes | Phase 3 |
| Hydrocortisone | None of these genes | Phase 3 |
| Ifinatamab Deruxtecan | None of these genes | Phase 3 |
| Ipatasertib | None of these genes | Phase 3 |
| Ipilimumab | None of these genes | Phase 3 |
| Ketoconazole | None of these genes | Phase 3 |
| Lanreotide | None of these genes | Phase 3 |
| Lenalidomide | None of these genes | Phase 3 |
| Litgenprostucel-L | None of these genes | Phase 3 |
| Lutetium Lu177 Edotreotide | None of these genes | Phase 3 |
| Lutetium Lu 177 Zadavotide Guraxetan | None of these genes | Phase 3 |
| Lutetium Oxodotreotide | None of these genes | Phase 3 |
| Masitinib | None of these genes | Phase 3 |
| Metformin | None of these genes | Phase 3 |
| Methylprednisolone | None of these genes | Phase 3 |
| Mevrometostat | None of these genes | Phase 3 |
| Niraparib | None of these genes | Phase 3 |
| Nivolumab | None of these genes | Phase 3 |
| Olaparib | None of these genes | Phase 3 |
| Opevesostat | None of these genes | Phase 3 |
| Orteronel | None of these genes | Phase 3 |
| Oxycodone | None of these genes | Phase 3 |
| Paclitaxel | None of these genes | Phase 3 |
| Padeliporfin | None of these genes | Phase 3 |
| Pasritamig | None of these genes | Phase 3 |
| Pembrolizumab | None of these genes | Phase 3 |
| Picoplatin | None of these genes | Phase 3 |
| Prednisolone | None of these genes | Phase 3 |
| Pregabalin | None of these genes | Phase 3 |
| Prinomastat | None of these genes | Phase 3 |
| Radium | None of these genes | Phase 3 |
| Rebimastat | None of these genes | Phase 3 |
| Regramostim | None of these genes | Phase 3 |
| Rezvilutamide | None of these genes | Phase 3 |
| Rilimogene Galvacirepvec | None of these genes | Phase 3 |
| Rucaparib | None of these genes | Phase 3 |
| Sabizabulin | None of these genes | Phase 3 |
| Saruparib | None of these genes | Phase 3 |
| Satraplatin | None of these genes | Phase 3 |
| Stapuldencel | None of these genes | Phase 3 |
| Strontium Chloride | None of these genes | Phase 3 |
| Sufentanil | None of these genes | Phase 3 |
| Sunitinib | None of these genes | Phase 3 |
| Suramin | None of these genes | Phase 3 |
| Tamsulosin | None of these genes | Phase 3 |
| Tasquinimod | None of these genes | Phase 3 |
| Testosterone | None of these genes | Phase 3 |
| Thalidomide | None of these genes | Phase 3 |
| Topsalysin | None of these genes | Phase 3 |
| Tranexamic Acid | None of these genes | Phase 3 |
| Triptorelin | None of these genes | Phase 3 |
| Valacyclovir | None of these genes | Phase 3 |
| Vinblastine | None of these genes | Phase 3 |
| Vitamin E | None of these genes | Phase 3 |
| Votumumab | None of these genes | Phase 3 |
| Votumumab 99tc | None of these genes | Phase 3 |
| Zibotentan | None of these genes | Phase 3 |
| Celecoxib | None of these genes | Phase 2/3 |
| Cyclosporine | None of these genes | Phase 2/3 |
| Fasudil | None of these genes | Phase 2/3 |
| Finasteride | None of these genes | Phase 2/3 |
| Leflunomide | None of these genes | Phase 2/3 |
| Lenograstim | None of these genes | Phase 2/3 |
| Melphalan | None of these genes | Phase 2/3 |
| Padoporfin | None of these genes | Phase 2/3 |
| Sirolimus | None of these genes | Phase 2/3 |
| Tacrolimus Anhydrous | None of these genes | Phase 2/3 |
| 2-Methoxyestradiol | None of these genes | Phase 2 |
| Abc-294640 | None of these genes | Phase 2 |
| Abituzumab | None of these genes | Phase 2 |
| Abivertinib | None of these genes | Phase 2 |
| Acyline | None of these genes | Phase 2 |
| Adavosertib | None of these genes | Phase 2 |
| Adebrelimab | None of these genes | Phase 2 |
| Adecatumumab | None of these genes | Phase 2 |
| Afatinib | None of these genes | Phase 2 |
| Aldesleukin | None of these genes | Phase 2 |
| Alisertib | None of these genes | Phase 2 |
| Allantoin | None of these genes | Phase 2 |
| Alvocidib | None of these genes | Phase 2 |
| Amg-208 | None of these genes | Phase 2 |
| Aminoglutethimide | None of these genes | Phase 2 |
| Antineoplaston A10 | None of these genes | Phase 2 |
| Apatorsen | None of these genes | Phase 2 |
| Apatorsen Sodium | None of these genes | Phase 2 |
| Arginine | None of these genes | Phase 2 |
| Arsenic Trioxide | None of these genes | Phase 2 |
| Arundine | None of these genes | Phase 2 |
| Ascorbic Acid | None of these genes | Phase 2 |
| Avelumab | None of these genes | Phase 2 |
| Axelopran | None of these genes | Phase 2 |
| Axitinib | None of these genes | Phase 2 |
| Azacitidine | None of these genes | Phase 2 |
| Azd-5312 | None of these genes | Phase 2 |
| Bafetinib | None of these genes | Phase 2 |
| Bcg Vaccine | None of these genes | Phase 2 |
| Belzutifan | None of these genes | Phase 2 |
| Berzosertib | None of these genes | Phase 2 |
| Bi-2536 | None of these genes | Phase 2 |
| Bintrafusp Alfa | None of these genes | Phase 2 |
| Bortezomib | None of these genes | Phase 2 |
| Bromelains | None of these genes | Phase 2 |
| Bryostatin 1 | None of these genes | Phase 2 |
| Buparlisib | None of these genes | Phase 2 |
| Capecitabine | None of these genes | Phase 2 |
| Carfilzomib | None of these genes | Phase 2 |
| Carlumab | None of these genes | Phase 2 |
| Carmustine | None of these genes | Phase 2 |
| Carotuximab | None of these genes | Phase 2 |
| Catequentinib | None of these genes | Phase 2 |
| Cediranib | None of these genes | Phase 2 |
| Cemiplimab | None of these genes | Phase 2 |
| Cep-11981 | None of these genes | Phase 2 |
| Ceralasertib | None of these genes | Phase 2 |
| Cetrelimab | None of these genes | Phase 2 |
| Cetuximab | None of these genes | Phase 2 |
| Cgc-11047 | None of these genes | Phase 2 |
| Cilengitide | None of these genes | Phase 2 |
| Cinacalcet | None of these genes | Phase 2 |
| Cisplatin | None of these genes | Phase 2 |
| Cixutumumab | None of these genes | Phase 2 |
| Colchicine | None of these genes | Phase 2 |
| Cp-461 | None of these genes | Phase 2 |
| Cravacitinib | None of these genes | Phase 2 |
| Curcumin | None of these genes | Phase 2 |
| Custirsen Sodium | None of these genes | Phase 2 |
| Cyanocobalamin | None of these genes | Phase 2 |
| Cyclophosphamide Anhydrous | None of these genes | Phase 2 |
| Cytarabine | None of these genes | Phase 2 |
| Danusertib | None of these genes | Phase 2 |
| Dapagliflozin | None of these genes | Phase 2 |
| Daratumumab | None of these genes | Phase 2 |
| Datopotamab Deruxtecan | None of these genes | Phase 2 |
| Davamotecan Pegadexamer | None of these genes | Phase 2 |
| Digoxin | None of these genes | Phase 2 |
| Disitamab Vedotin | None of these genes | Phase 2 |
| Dolastatin-10 | None of these genes | Phase 2 |
| Dovitinib | None of these genes | Phase 2 |
| Doxazosin | None of these genes | Phase 2 |
| Doxercalciferol | None of these genes | Phase 2 |
| Dupilumab | None of these genes | Phase 2 |
| Durvalumab | None of these genes | Phase 2 |
| Edodekin Alfa | None of these genes | Phase 2 |
| Efavirenz | None of these genes | Phase 2 |
| Eflornithine | None of these genes | Phase 2 |
| Elraglusib | None of these genes | Phase 2 |
| Enfortumab Vedotin | None of these genes | Phase 2 |
| Enoblituzumab | None of these genes | Phase 2 |
| Enzastaurin | None of these genes | Phase 2 |
| Epirubicin | None of these genes | Phase 2 |
| Epothilone D | None of these genes | Phase 2 |
| Erdafitinib | None of these genes | Phase 2 |
| Eribulin | None of these genes | Phase 2 |
| Erlotinib | None of these genes | Phase 2 |
| Estetrol Anhydrous | None of these genes | Phase 2 |
| Estrogen | None of these genes | Phase 2 |
| Estrogens, Conjugated | None of these genes | Phase 2 |
| Etaracizumab | None of these genes | Phase 2 |
| Etodolac | None of these genes | Phase 2 |
| Etoricoxib | None of these genes | Phase 2 |
| Etrumadenant | None of these genes | Phase 2 |
| Evofosfamide | None of these genes | Phase 2 |
| Exatecan | None of these genes | Phase 2 |
| Exemestane | None of these genes | Phase 2 |
| Exicorilant | None of these genes | Phase 2 |
| Exisulind | None of these genes | Phase 2 |
| Ezetimibe | None of these genes | Phase 2 |
| Fapi Ga-68 | None of these genes | Phase 2 |
| Fenretinide | None of these genes | Phase 2 |
| Fexapotide | None of these genes | Phase 2 |
| Figitumumab | None of these genes | Phase 2 |
| Filgrastim | None of these genes | Phase 2 |
| Flibanserin | None of these genes | Phase 2 |
| Flucytosine | None of these genes | Phase 2 |
| Fluorouracil | None of these genes | Phase 2 |
| Fluvastatin | None of these genes | Phase 2 |
| Folic Acid | None of these genes | Phase 2 |
| Fulvestrant | None of these genes | Phase 2 |
| Ganciclovir | None of these genes | Phase 2 |
| Ganetespib | None of these genes | Phase 2 |
| Gataparsen | None of these genes | Phase 2 |
| Gefitinib | None of these genes | Phase 2 |
| Gemcitabine | None of these genes | Phase 2 |
| Genistein | None of these genes | Phase 2 |
| Glutamine | None of these genes | Phase 2 |
| Glycerol Phenylbutyrate | None of these genes | Phase 2 |
| Glycyrrhizin | None of these genes | Phase 2 |
| Golimumab | None of these genes | Phase 2 |
| Gossypol | None of these genes | Phase 2 |
| Gozetotide | None of these genes | Phase 2 |
| Grapiprant | None of these genes | Phase 2 |
| Gti-2040 | None of these genes | Phase 2 |
| Gtx-758 | None of these genes | Phase 2 |
| Hiltonol | None of these genes | Phase 2 |
| Hmb | None of these genes | Phase 2 |
| Huj591 111in | None of these genes | Phase 2 |
| Huj591 177lu | None of these genes | Phase 2 |
| Human Immunoglobulin G | None of these genes | Phase 2 |
| Hyaluronidase (Human Recombinant) | None of these genes | Phase 2 |
| Hydroxychloroquine | None of these genes | Phase 2 |
| Iadademstat | None of these genes | Phase 2 |
| Ibrutinib | None of these genes | Phase 2 |
| Icosapent | None of these genes | Phase 2 |
| Imaradenant | None of these genes | Phase 2 |
| Imatinib | None of these genes | Phase 2 |
| Imifoplatin | None of these genes | Phase 2 |
| Inavolisib | None of these genes | Phase 2 |
| Inbakicept | None of these genes | Phase 2 |
| Incomplete Freund'S Adjuvant | None of these genes | Phase 2 |
| Indomethacin | None of these genes | Phase 2 |
| Indoximod | None of these genes | Phase 2 |
| Inecalcitol | None of these genes | Phase 2 |
| Interferon Alfa | None of these genes | Phase 2 |
| Interferon Alfa-2b | None of these genes | Phase 2 |
| Interleukin-7 | None of these genes | Phase 2 |
| Intetumumab | None of these genes | Phase 2 |
| Irinotecan | None of these genes | Phase 2 |
| Irofulven | None of these genes | Phase 2 |
| Irx-4204 | None of these genes | Phase 2 |
| Isoflavone | None of these genes | Phase 2 |
| Isophenoxodiol | None of these genes | Phase 2 |
| Isosorbide | None of these genes | Phase 2 |
| Isotretinoin | None of these genes | Phase 2 |
| Ispinesib | None of these genes | Phase 2 |
| Itraconazole | None of these genes | Phase 2 |
| Ivonescimab | None of these genes | Phase 2 |
| Ixabepilone | None of these genes | Phase 2 |
| J591 | None of these genes | Phase 2 |
| Lapatinib | None of these genes | Phase 2 |
| Lestaurtinib | None of these genes | Phase 2 |
| Letrozole | None of these genes | Phase 2 |
| Leucovorin | None of these genes | Phase 2 |
| Litronesib | None of these genes | Phase 2 |
| Lomustine | None of these genes | Phase 2 |
| Lorigerlimab | None of these genes | Phase 2 |
| Luxdegalutamide | None of these genes | Phase 2 |
| Lycopene | None of these genes | Phase 2 |
| Masofaniten | None of these genes | Phase 2 |
| Mdx-070 | None of these genes | Phase 2 |
| Memantine | None of these genes | Phase 2 |
| Menadione | None of these genes | Phase 2 |
| Methotrexate | None of these genes | Phase 2 |
| Methoxsalen | None of these genes | Phase 2 |
| Metronidazole | None of these genes | Phase 2 |
| Mifepristone | None of these genes | Phase 2 |
| Mipsagargin | None of these genes | Phase 2 |
| Mk-2206 | None of these genes | Phase 2 |
| Mln-591rl | None of these genes | Phase 2 |
| Molgramostim | None of these genes | Phase 2 |
| Muparfostat | None of these genes | Phase 2 |
| Nalotimagene Carmaleucel | None of these genes | Phase 2 |
| Naltrexone | None of these genes | Phase 2 |
| Naproxen | None of these genes | Phase 2 |
| Navarixin Anhydrous | None of these genes | Phase 2 |
| Navitoclax | None of these genes | Phase 2 |
| Nebentan | None of these genes | Phase 2 |
| Nelitolimod | None of these genes | Phase 2 |
| Neratinib | None of these genes | Phase 2 |
| Niclosamide | None of these genes | Phase 2 |
| Nintedanib | None of these genes | Phase 2 |
| Nitrogen | None of these genes | Phase 2 |
| Nogapendekin Alfa | None of these genes | Phase 2 |
| Nogapendekin Alfa Inbakicept | None of these genes | Phase 2 |
| Nordihydroguaiaretic Acid | None of these genes | Phase 2 |
| Oblimersen Sodium | None of these genes | Phase 2 |
| Ocifisertib | None of these genes | Phase 2 |
| Octreotide | None of these genes | Phase 2 |
| Olaratumab | None of these genes | Phase 2 |
| Oleclumab | None of these genes | Phase 2 |
| Omacetaxine Mepesuccinate | None of these genes | Phase 2 |
| Omeprazole | None of these genes | Phase 2 |
| Onabotulinumtoxina | None of these genes | Phase 2 |
| Onvansertib | None of these genes | Phase 2 |
| Opolimogene Capmilisbac | None of these genes | Phase 2 |
| Osimertinib | None of these genes | Phase 2 |
| Oxaliplatin | None of these genes | Phase 2 |
| Ozarelix | None of these genes | Phase 2 |
| Paclitaxel Poliglumex | None of these genes | Phase 2 |
| Pacritinib | None of these genes | Phase 2 |
| Palbociclib | None of these genes | Phase 2 |
| Pamiparib | None of these genes | Phase 2 |
| Panitumumab | None of these genes | Phase 2 |
| Panobinostat | None of these genes | Phase 2 |
| Pantoprazole | None of these genes | Phase 2 |
| Paricalcitol | None of these genes | Phase 2 |
| Pasireotide | None of these genes | Phase 2 |
| Patritumab Deruxtecan | None of these genes | Phase 2 |
| Patupilone | None of these genes | Phase 2 |
| Pazopanib | None of these genes | Phase 2 |
| Pegfilgrastim | None of these genes | Phase 2 |
| Pelareorep | None of these genes | Phase 2 |
| Pemetrexed | None of these genes | Phase 2 |
| Perenostobart | None of these genes | Phase 2 |
| Perifosine | None of these genes | Phase 2 |
| Perillyl Alcohol | None of these genes | Phase 2 |
| Pertuzumab | None of these genes | Phase 2 |
| Pexidartinib | None of these genes | Phase 2 |
| Phenelzine | None of these genes | Phase 2 |
| Phenylacetic Acid | None of these genes | Phase 2 |
| Phenylbutanoic Acid | None of these genes | Phase 2 |
| Phenytoin | None of these genes | Phase 2 |
| Pidilizumab | None of these genes | Phase 2 |
| Piflufolastat | None of these genes | Phase 2 |
| Pioglitazone | None of these genes | Phase 2 |
| Platinum | None of these genes | Phase 2 |
| Pomalidomide | None of these genes | Phase 2 |
| Pracinostat | None of these genes | Phase 2 |
| Propranolol | None of these genes | Phase 2 |
| Pruxelutamide | None of these genes | Phase 2 |
| Pyruvate | None of these genes | Phase 2 |
| Qs-21 | None of these genes | Phase 2 |
| Quemliclustat | None of these genes | Phase 2 |
| Quinacrine | None of these genes | Phase 2 |
| Racemetyrosine | None of these genes | Phase 2 |
| Raloxifene | None of these genes | Phase 2 |
| Ramucirumab | None of these genes | Phase 2 |
| Relacorilant | None of these genes | Phase 2 |
| Retaspimycin | None of these genes | Phase 2 |
| Retlirafusp Alfa | None of these genes | Phase 2 |
| Rg-4733 | None of these genes | Phase 2 |
| Ridaforolimus | None of these genes | Phase 2 |
| Rilvegostomig | None of these genes | Phase 2 |
| Rintatolimod | None of these genes | Phase 2 |
| Ritonavir | None of these genes | Phase 2 |
| Rivoceranib | None of these genes | Phase 2 |
| Romidepsin | None of these genes | Phase 2 |
| Rubitecan | None of these genes | Phase 2 |
| Rutin | None of these genes | Phase 2 |
| Ruxolitinib | None of these genes | Phase 2 |
| Sabarubicin | None of these genes | Phase 2 |
| Sacituzumab Govitecan | None of these genes | Phase 2 |
| Sacituzumab Tirumotecan | None of these genes | Phase 2 |
| Sagopilone | None of these genes | Phase 2 |
| Samarium | None of these genes | Phase 2 |
| Samotolisib | None of these genes | Phase 2 |
| Sapanisertib | None of these genes | Phase 2 |
| Saracatinib | None of these genes | Phase 2 |
| Sargramostim | None of these genes | Phase 2 |
| Savolitinib | None of these genes | Phase 2 |
| Selenomethionine | None of these genes | Phase 2 |
| Selinexor | None of these genes | Phase 2 |
| Semaxanib | None of these genes | Phase 2 |
| Senaparib | None of these genes | Phase 2 |
| Sepantronium | None of these genes | Phase 2 |
| Sephb4-Hsa | None of these genes | Phase 2 |
| Seviteronel | None of these genes | Phase 2 |
| Silibinin | None of these genes | Phase 2 |
| Siltuximab | None of these genes | Phase 2 |
| Simvastatin | None of these genes | Phase 2 |
| Sinecatechins | None of these genes | Phase 2 |
| Sodium Chloride | None of these genes | Phase 2 |
| Sonolisib | None of these genes | Phase 2 |
| Sorafenib | None of these genes | Phase 2 |
| Sulforaphane | None of these genes | Phase 2 |
| Sx-682 | None of these genes | Phase 2 |
| Tak-448 | None of these genes | Phase 2 |
| Tamoxifen | None of these genes | Phase 2 |
| Tandutinib | None of these genes | Phase 2 |
| Tanespimycin | None of these genes | Phase 2 |
| Tarenflurbil | None of these genes | Phase 2 |
| Tarlatamab | None of these genes | Phase 2 |
| Tasadenoturev | None of these genes | Phase 2 |
| Tasidotin | None of these genes | Phase 2 |
| Tecemotide | None of these genes | Phase 2 |
| Technetium Tc-99m Trofolastat Chloride | None of these genes | Phase 2 |
| Telaglenastat | None of these genes | Phase 2 |
| Tempol | None of these genes | Phase 2 |
| Temsirolimus | None of these genes | Phase 2 |
| Terbinafine | None of these genes | Phase 2 |
| Tesetaxel | None of these genes | Phase 2 |
| Testosterone Cypionate | None of these genes | Phase 2 |
| Testosterone Enanthate | None of these genes | Phase 2 |
| Testosterone Undecanoate | None of these genes | Phase 2 |
| Tiomolibdate Choline | None of these genes | Phase 2 |
| Tiomolibdate Diammonium | None of these genes | Phase 2 |
| Tipifarnib | None of these genes | Phase 2 |
| Tirbanibulin | None of these genes | Phase 2 |
| Tislelizumab | None of these genes | Phase 2 |
| Tivantinib | None of these genes | Phase 2 |
| Tivozanib | None of these genes | Phase 2 |
| Tocilizumab | None of these genes | Phase 2 |
| Tomivosertib | None of these genes | Phase 2 |
| Topotecan | None of these genes | Phase 2 |
| Toremifene | None of these genes | Phase 2 |
| Trabectedin | None of these genes | Phase 2 |
| Trametinib | None of these genes | Phase 2 |
| Trastuzumab | None of these genes | Phase 2 |
| Trebananib | None of these genes | Phase 2 |
| Tremelimumab | None of these genes | Phase 2 |
| Tretinoin | None of these genes | Phase 2 |
| Triamcinolone Acetonide | None of these genes | Phase 2 |
| Triapine | None of these genes | Phase 2 |
| Trilostane | None of these genes | Phase 2 |
| Trimethoprim | None of these genes | Phase 2 |
| Triptorelin Acetate | None of these genes | Phase 2 |
| Tuvusertib | None of these genes | Phase 2 |
| Vadimezan | None of these genes | Phase 2 |
| Valemetostat | None of these genes | Phase 2 |
| Valproic Acid | None of these genes | Phase 2 |
| Vandetanib | None of these genes | Phase 2 |
| Vatalanib | None of these genes | Phase 2 |
| Veliparib | None of these genes | Phase 2 |
| Vemurafenib | None of these genes | Phase 2 |
| Vidutolimod | None of these genes | Phase 2 |
| Vinflunine | None of these genes | Phase 2 |
| Vinorelbine | None of these genes | Phase 2 |
| Vipivotide Tetraxetan | None of these genes | Phase 2 |
| Vobramitamab Duocarmazine | None of these genes | Phase 2 |
| Volrustomig | None of these genes | Phase 2 |
| Vorinostat | None of these genes | Phase 2 |
| Vudalimab | None of these genes | Phase 2 |
| Warfarin | None of these genes | Phase 2 |
| Zanzalintinib | None of these genes | Phase 2 |
| Zen-3694 | None of these genes | Phase 2 |
| Zenocutuzumab | None of these genes | Phase 2 |
| Zeprumetostat | None of these genes | Phase 2 |
| Zimberelimab | None of these genes | Phase 2 |
| 2-Deoxy-D-Glucose | None of these genes | Phase 1/2 |
| Abt-751 | None of these genes | Phase 1/2 |
| Acapatamab | None of these genes | Phase 1/2 |
| Adakitug | None of these genes | Phase 1/2 |
| Afuresertib | None of these genes | Phase 1/2 |
| Alobresib | None of these genes | Phase 1/2 |
| Amg-404 | None of these genes | Phase 1/2 |
| Apc-100 | None of these genes | Phase 1/2 |
| Apitolisib | None of these genes | Phase 1/2 |
| Asp-9521 | None of these genes | Phase 1/2 |
| Azd-9574 | None of these genes | Phase 1/2 |
| Balstilimab | None of these genes | Phase 1/2 |
| Bavdegalutamide | None of these genes | Phase 1/2 |
| Bavituximab | None of these genes | Phase 1/2 |
| Bempegaldesleukin | None of these genes | Phase 1/2 |
| Bms-777607 | None of these genes | Phase 1/2 |
| Camptothecin | None of these genes | Phase 1/2 |
| Cedazuridine | None of these genes | Phase 1/2 |
| Cfg-920 | None of these genes | Phase 1/2 |
| Coenzyme_A | None of these genes | Phase 1/2 |
| Copanlisib | None of these genes | Phase 1/2 |
| Cpi-1205 | None of these genes | Phase 1/2 |
| Ct-7001 | None of these genes | Phase 1/2 |
| Dactolisib | None of these genes | Phase 1/2 |
| Decitabine | None of these genes | Phase 1/2 |
| Dkn-01 | None of these genes | Phase 1/2 |
| Doxribtimine | None of these genes | Phase 1/2 |
| Ebastine | None of these genes | Phase 1/2 |
| Eltanexor | None of these genes | Phase 1/2 |
| Epacadostat | None of these genes | Phase 1/2 |
| F16il2 | None of these genes | Phase 1/2 |
| Fianlimab | None of these genes | Phase 1/2 |
| Fludrocortisone Acetate | None of these genes | Phase 1/2 |
| Gallium | None of these genes | Phase 1/2 |
| Gebasaxturev | None of these genes | Phase 1/2 |
| Gedatolisib | None of these genes | Phase 1/2 |
| Hafnium Oxide | None of these genes | Phase 1/2 |
| He3235 | None of these genes | Phase 1/2 |
| Hpn-424 | None of these genes | Phase 1/2 |
| Idronoxil | None of these genes | Phase 1/2 |
| Inobrodib | None of these genes | Phase 1/2 |
| Interferon Gamma-1b | None of these genes | Phase 1/2 |
| Ismidenon | None of these genes | Phase 1/2 |
| L-377202 | None of these genes | Phase 1/2 |
| Lenvatinib | None of these genes | Phase 1/2 |
| Lonafarnib | None of these genes | Phase 1/2 |
| Lopinavir | None of these genes | Phase 1/2 |
| Lutetium Lu-177 Psma-R2 | None of these genes | Phase 1/2 |
| Mcs-110 | None of these genes | Phase 1/2 |
| Midazolam | None of these genes | Phase 1/2 |
| Mln-2704 | None of these genes | Phase 1/2 |
| Nedisertib | None of these genes | Phase 1/2 |
| Nelfinavir | None of these genes | Phase 1/2 |
| Nezastomig | None of these genes | Phase 1/2 |
| Nezutatug | None of these genes | Phase 1/2 |
| Obi-3424 | None of these genes | Phase 1/2 |
| Oblimersen | None of these genes | Phase 1/2 |
| Odm-204 | None of these genes | Phase 1/2 |
| Odm-207 | None of these genes | Phase 1/2 |
| Onalespib | None of these genes | Phase 1/2 |
| Onapristone | None of these genes | Phase 1/2 |
| Onc-392 | None of these genes | Phase 1/2 |
| Pegargiminase | None of these genes | Phase 1/2 |
| Pocenbrodib | None of these genes | Phase 1/2 |
| Poliglusam | None of these genes | Phase 1/2 |
| Quercetin | None of these genes | Phase 1/2 |
| Ralaniten Acetate | None of these genes | Phase 1/2 |
| Retifanlimab | None of these genes | Phase 1/2 |
| Ribociclib | None of these genes | Phase 1/2 |
| Rilotumumab | None of these genes | Phase 1/2 |
| Rovalpituzumab Tesirine | None of these genes | Phase 1/2 |
| Tazemetostat | None of these genes | Phase 1/2 |
| Temozolomide | None of these genes | Phase 1/2 |
| Tildrakizumab | None of these genes | Phase 1/2 |
| Tinengotinib | None of these genes | Phase 1/2 |
| Trastuzumab Deruxtecan | None of these genes | Phase 1/2 |
| Trc-253 | None of these genes | Phase 1/2 |
| Tris(8-Hydroxyquinolinato)Gallium | None of these genes | Phase 1/2 |
| Tulmimetostat | None of these genes | Phase 1/2 |
| Verteporfin | None of these genes | Phase 1/2 |
| Xentuzumab | None of these genes | Phase 1/2 |
| Zalifrelimab | None of these genes | Phase 1/2 |
| Zoptarelin Doxorubicin | None of these genes | Phase 1/2 |
| Ab-001 | None of these genes | Phase 1 |
| Abbv-744 | None of these genes | Phase 1 |
| Abiraterone Decanoate | None of these genes | Phase 1 |
| Agatolimod | None of these genes | Phase 1 |
| Alcohol | None of these genes | Phase 1 |
| Aluminum Hydroxide | None of these genes | Phase 1 |
| Amg-900 | None of these genes | Phase 1 |
| Anakinra | None of these genes | Phase 1 |
| Apvo-414 | None of these genes | Phase 1 |
| Asg-5me | None of these genes | Phase 1 |
| Atirmociclib | None of these genes | Phase 1 |
| Azd3514 | None of these genes | Phase 1 |
| Azd-5363 | None of these genes | Phase 1 |
| Azd-8186 | None of these genes | Phase 1 |
| Belinostat | None of these genes | Phase 1 |
| Birabresib | None of these genes | Phase 1 |
| Botensilimab | None of these genes | Phase 1 |
| Burixafor | None of these genes | Phase 1 |
| Calcifediol Anhydrous | None of these genes | Phase 1 |
| Calcium Carbonate | None of these genes | Phase 1 |
| Cannabidiol | None of these genes | Phase 1 |
| Cc-115 | None of these genes | Phase 1 |
| Cc-94676 | None of these genes | Phase 1 |
| Cdx-301 | None of these genes | Phase 1 |
| Charcoal, Activated | None of these genes | Phase 1 |
| Chembl347534 | None of these genes | Phase 1 |
| Cirmtuzumab | None of these genes | Phase 1 |
| Clarithromycin | None of these genes | Phase 1 |
| Crizotinib | None of these genes | Phase 1 |
| Ctt-1057 | None of these genes | Phase 1 |
| Cupric Chloride | None of these genes | Phase 1 |
| Cx-5461 | None of these genes | Phase 1 |
| Cyt-500 177lu | None of these genes | Phase 1 |
| Dalpiciclib | None of these genes | Phase 1 |
| Denifanstat | None of these genes | Phase 1 |
| Dextromethorphan | None of these genes | Phase 1 |
| Diazepinomicin | None of these genes | Phase 1 |
| Disulfiram | None of these genes | Phase 1 |
| Dordaviprone | None of these genes | Phase 1 |
| Dotmp Sm-153 | None of these genes | Phase 1 |
| Edicotinib | None of these genes | Phase 1 |
| Efineptakin Alfa | None of these genes | Phase 1 |
| Elesclomol | None of these genes | Phase 1 |
| Emibetuzumab | None of these genes | Phase 1 |
| Eniluracil | None of these genes | Phase 1 |
| Entinostat | None of these genes | Phase 1 |
| Entrectinib | None of these genes | Phase 1 |
| Etanercept | None of these genes | Phase 1 |
| Ferric Carboxymaltose | None of these genes | Phase 1 |
| Ferric Oxyhydroxide | None of these genes | Phase 1 |
| Ferrous Sulfate | None of these genes | Phase 1 |
| Flotufolastat | None of these genes | Phase 1 |
| Fludarabine | None of these genes | Phase 1 |
| Foxy-5 | None of these genes | Phase 1 |
| Gpi-0100 | None of these genes | Phase 1 |
| Gridegalutamide | None of these genes | Phase 1 |
| Gsk-2636771 | None of these genes | Phase 1 |
| Gsk2816126 | None of these genes | Phase 1 |
| Harmine | None of these genes | Phase 1 |
| Hmn-214 | None of these genes | Phase 1 |
| Imc-Cs4 | None of these genes | Phase 1 |
| Imexon | None of these genes | Phase 1 |
| Imiquimod | None of these genes | Phase 1 |
| Iodine | None of these genes | Phase 1 |
| Iron Isomaltoside 1000 | None of these genes | Phase 1 |
| Irosustat | None of these genes | Phase 1 |
| Isovanillin | None of these genes | Phase 1 |
| Keyhole Limpet Hemocyanin | None of these genes | Phase 1 |
| Lapachone | None of these genes | Phase 1 |
| Lartesertib | None of these genes | Phase 1 |
| Lb-100 | None of these genes | Phase 1 |
| Lidocaine | None of these genes | Phase 1 |
| Lithium Carbonate | None of these genes | Phase 1 |
| Magrolimab | None of these genes | Phase 1 |
| Mgd-009 | None of these genes | Phase 1 |
| Mip-1095 | None of these genes | Phase 1 |
| Mip-1095 I-131 | None of these genes | Phase 1 |
| Mitotane | None of these genes | Phase 1 |
| Mk-0752 | None of these genes | Phase 1 |
| Mk-4721 | None of these genes | Phase 1 |
| Molibresib | None of these genes | Phase 1 |
| Motexafin Lutetium | None of these genes | Phase 1 |
| Mubritinib | None of these genes | Phase 1 |
| Mu-J591 | None of these genes | Phase 1 |
| Mvt-5873 | None of these genes | Phase 1 |
| Nerofe | None of these genes | Phase 1 |
| Oric-101 | None of these genes | Phase 1 |
| Palazestrant | None of these genes | Phase 1 |
| Pelgifatamab | None of these genes | Phase 1 |
| Plumbagin | None of these genes | Phase 1 |
| Pulrodemstat | None of these genes | Phase 1 |
| Rimiducid | None of these genes | Phase 1 |
| Rocakinogene Sifuplasmid | None of these genes | Phase 1 |
| Sasanlimab | None of these genes | Phase 1 |
| Selenious Acid | None of these genes | Phase 1 |
| Selenium | None of these genes | Phase 1 |
| Selicrelumab | None of these genes | Phase 1 |
| Serdemetan | None of these genes | Phase 1 |
| Sgi-1776 | None of these genes | Phase 1 |
| Sitravatinib | None of these genes | Phase 1 |
| Somatostatin | None of these genes | Phase 1 |
| Sonidegib | None of these genes | Phase 1 |
| Sudocetaxel | None of these genes | Phase 1 |
| Telmisartan | None of these genes | Phase 1 |
| Theophylline Anhydrous | None of these genes | Phase 1 |
| Tigapotide | None of these genes | Phase 1 |
| Triamcinolone | None of these genes | Phase 1 |
| Tributyrin | None of these genes | Phase 1 |
| Tucotuzumab Celmoleukin | None of these genes | Phase 1 |
| Vactosertib | None of these genes | Phase 1 |
| Vandortuzumab | None of these genes | Phase 1 |
| Vandortuzumab Vedotin | None of these genes | Phase 1 |
| Varlilumab | None of these genes | Phase 1 |
| Venetoclax | None of these genes | Phase 1 |
| Vistusertib | None of these genes | Phase 1 |
| Zirconium Zr-89-Desferrioxamine-Iab22m2c | None of these genes | Phase 1 |
| Acetic Acid | None of these genes | Early phase 1 |
| Alectinib | None of these genes | Early phase 1 |
| Alpelisib | None of these genes | Early phase 1 |
| Anastrozole | None of these genes | Early phase 1 |
| Cobimetinib | None of these genes | Early phase 1 |
| Desmopressin | None of these genes | Early phase 1 |
| Osanetant | None of these genes | Early phase 1 |
| Rituximab | None of these genes | Early phase 1 |
| Teprotumumab | None of these genes | Early phase 1 |
| Tirzepatide | None of these genes | Early phase 1 |
| Trastuzumab Emtansine | None of these genes | Early phase 1 |
| Ursolic Acid | None of these genes | Early phase 1 |
| Vismodegib | None of these genes | Early phase 1 |
| Doxycycline Anhydrous | None of these genes | Investigational new drug |
| Gamma-Tocotrienol | None of these genes | Investigational new drug |
| Gsk-650394 | None of these genes | Investigational new drug |
| (+)-Tranylcypromine | None of these genes | Preclinical |
| Tranylcypromine | None of these genes | Preclinical |
| 2-Mercaptoethanesulfonic Acid | None of these genes | Unknown |
| Esmolol | None of these genes | Unknown |
| Flotufolastat F-18 Gallium | None of these genes | Unknown |
| Ifosfamide | None of these genes | Unknown |
| Indole-3-Carbinol | None of these genes | Unknown |
| Lovastatin | None of these genes | Unknown |
| Methylselenocysteine | None of these genes | Unknown |
| Propofol | None of these genes | Unknown |
| Remifentanil | None of these genes | Unknown |
| Rocuronium | None of these genes | Unknown |
| Sevoflurane | None of these genes | Unknown |
| Thiopental | None of these genes | Unknown |
| Topixantrone | None of these genes | Unknown |
| Tozinameran | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.